通过生物模拟超分子受体化霍夫迈斯特效应
Weibin Lin1, Gengwu Zhang1,2, Xuanfu Zhu1
1Chemistry Program, Physical Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia.
Journal of the American Chemical Society
|June 6, 2023
概括
研究人员开发了一种新型的合成体复合物,可以抵消霍夫迈斯特效应,通过防止阴离子诱导的沉,在水溶液中保持酶蛋白活性.
科学领域:
- 生物化学
- 超分子化学
- 蛋白质科学
背景情况:
- 霍夫迈斯特效应描述了离子如何改变蛋白质的溶解性和功能.
- 虽然存在合成的阳离子识别受体,但没有一个能够解决霍夫迈斯特诱导的蛋白质扰动.
- 克服这些干扰对于在各种条件下维持蛋白质活性至关重要.
研究的目的:
- 研究一种能够减轻霍夫迈斯特对自然蛋白质的影响的合成宿主.
- 在具有挑战性的离子条件下证明一种新复合物的蛋白质可溶性和功能能力.
主要方法:
- 一个作为外受体的质子化小分子复合物的合成.
- 在不同离子的水性介质中评估体复合物的溶解性行为.
- 在通常发生离子诱导沉的条件下测试溶酶活性.
主要成果:
- 子复合物表现出非霍夫迈斯特溶解性,只有其化物复合物保持溶解性.
- 即使在沉离子条件下,在复合体的存在下,也成功保持了酶活性.
- 这代表了合成阳离子受体在生物系统中克服霍夫迈斯特效应的第一例.
结论:
- 合成子复合物可以有效地抵消霍夫迈斯特对自然蛋白质的影响.
- 这种方法提供了稳定溶液中的蛋白质的新策略,扩大了它们的潜在应用.
- 这些发现为设计定制受体在复杂环境中控制蛋白质行为开辟了道路.
相关概念视频
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Intracellular Hormone Receptors
55.6K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
55.6K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K


